Celsion Appoints Jeffrey Church as CFO
Celsion Corporation, a biotechnology drug development company, has appointed Jeffrey Church as vice president and chief financial officer (CFO).
Church brings more than 30 years of experience in financial management to Celsion, the majority of which are as a CFO. Prior to Celsion, he served as CFO for Alba Therapeutics, Novavax, GenVec, and Meridian Medical Technologies. Church has extensive experience in corporate finance, mergers and acquisitions, investor and Wall Street relations, and SEC reporting. He is a certified public accountant (CPA) and earned a BSc in Accounting, Summa Cum Laude from the University of Maryland.
Comments are closed.